We’re honored to have two products (Microlux DL and Bio/Screen) featured in this list of products to help fight oral cancer from The Daily Floss.
Toluidine blue staining in the detection of oral precancerous and malignant lesions.
Silverman S Jr, Mioltorati C, Barbosa J.
One hundred thirty-two consecutive patients suspected of having malignant or precancerous oral lesions were studied by comparing toluidine blue dye uptake clinically with a simultaneous biopsy. The histopathologic diagnosis confirmed 57 squamous carcinomas, 42 epithelial dysplasias, and 33 benign mucosal changes. Overall accuracy of the toluidine blue uptake was 91%. In the dysplastic and malignant lesions the false negatives were 2%, and there were 30% false positives in the benign lesions. It was concluded that toluidine blue staining is a useful adjunct to careful examination, clinical judgment, and biopsy.
For more references on OraBlu:
Increased Predictability in Tooth Shade-Matching
By: Kelvin I. Afrashtehfar, DDS, MSc(C)
Regardless of the operator’s gender, training and experience, shade-matching ability in the clinical practice and the dental laboratory improves significantly when conventional lighting is modified by light-correction. Accurate shade selection that allows restorations to match the natural dentition positively influences the patient’s appearance and esthetic self-esteem.
To view the full article:
Durrill Pinto, today at the GNYACD, Pearl River NY
Thank you SAS Excluvias for sharing these images of the SEMO mtg. happening today Sociedad Española de Medicina. Courtesy of Sally Bustos.